Results 141 to 150 of about 11,119 (206)
Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching
Pediatric Dermatology, EarlyView.ABSTRACT Background
Hidradenitis suppurativa (HS) causes significant morbidity in children. Treatment patterns across sex, race, and ethnicity in pediatric HS have not been thoroughly evaluated. We aim to characterize treatment patterns in pediatric HS, including (1) time to treatment initiation, (2) first prescribed HS treatment, and (3) time to ...Shaliz Aflatooni, Andrea Ure, Kimberly Smart, Julian A. Cortes, Gabriela Palma, Nicole Johnsen, Yvonne Nong, April W. Armstrong +7 morewiley +1 more sourceSerious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative
Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1514-1521, June 2026.The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel Joel L. Weissfeld, Geetha S. Iyer, Suna C. Seo, Andrew Giffin, Andrew L. Simon, Sheryl A. Kluberg, Emma R. Hoffman, Jamal T. Jones, Sarah K. Dutcher, Joyce A. Korvick +9 morewiley +1 more sourceScrotal Abscess Mimicking Fixed Drug Eruption Under Ibuprofen Therapy: A Diagnostic Pitfall
Clinical Case Reports, Volume 14, Issue 5, May 2026.ABSTRACT
Concurrent NSAID therapy can pharmacologically mask early scrotal abscess, generating a presentation that fulfills clinical and historical criteria for fixed drug eruption. Ibuprofen simultaneously acts as a recognized causative agent and suppresses infectious inflammatory signs.Youssef Maachi, Amine ELBoustani, Amine Salim Lalaoui, Amine Slaoui, Tariq Karmouni, Abdelatif Koutani, Khalid Elkhader +6 morewiley +1 more sourceThe Cutaneous Lesions of Dioxin Exposure: Lessons from the Poisoning of Victor Yushchenko [PDF]
, 2017 Several million people are exposed to dioxin and dioxin-like compounds, primarily through food consumption. Skin lesions historically called "chloracne” are the most specific sign of abnormal dioxin exposure and classically used as a key marker in humans.Barde, Caroline, Becker, Minerva, Carraux, Pierre, Descombes, Patrick, Fontao, Fabienne, Fontao, Lionel, Kaya, Guerkan, Mottu, Florence, Pardo, Bruno, Pham, Xuan-Cuong, Saurat, Jean-Hilaire, Saxer-Sekulic, Nikolina, Schaad, Olivier, Schmid, Peter, Sorg, Olivier, Zennegg, Markus +15 morecore Evaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross‐Sectional Study
Health Science Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background and Aim
Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients and analyze their correlation with disease severity to identify potential biomarkers of ...Zeinab Aryanian, Shahin Hamzelou, Haseeb Bazaz, Zahra Saffarian, Abolfazl Zendedel, Fatemeh Saberi, Azadeh Khayyat, Parvaneh Hatami +7 morewiley +1 more sourceCarrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians
Pregnancy, Volume 2, Issue 3, May 2026.Abstract
Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze +5 morewiley +1 more sourceReal‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry
United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.ABSTRACT Background
Upadacitinib (UPA) is the first oral Janus kinase (JAK) inhibitor approved for the treatment of Crohn's disease (CD). Real‐world data, particularly from large nationwide cohorts, remain limited. This study aimed to evaluate the real‐world effectiveness, safety, and treatment persistence of UPA in patients with CD.M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos +51 morewiley +1 more sourceRisk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
The Journal of Dermatology, Volume 53, Issue 5, Page 758-773, May 2026.ABSTRACT
Vitiligo is a chronic autoimmune depigmenting disease characterized by loss of pigment in the skin, hair, or both. As treatment options evolve, particularly with the emergence of oral Janus kinase inhibitors and dual Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor, it is essential to assess ...Kennedy Cook, Nada M. Elbuluk, Roni Adiri, Alexandre Lejeune, Thomas Edwards, Milena A. Gianfrancesco, Scott P. Kelly, Tatjana Lukic, Edward Nagy, Samantha K. Kurosky, Lynne Napatalung, Iltefat Hamzavi +11 morewiley +1 more sourceSuper‐Response to Guselkumab Treatment in Patients With Moderate‐to‐Severe Psoriasis: Real‐World Data With Up to Five Years of Follow‐Up in The Czech Republic
International Journal of Dermatology, Volume 65, Issue 5, Page 980-990, May 2026.Super‐response to Guselkumab. ABSTRACT Background
Guselkumab, a selective interleukin (IL)‐23 inhibitor, is approved for the treatment of moderate‐to‐severe plaque psoriasis. While randomized clinical trials have introduced the concept of “super‐responders” (SRe)—patients achieving complete skin clearance (Psoriasis Area and Severity Index [PASI] 100 ...Martina Kojanova, Daniela Pejrilova, Jorga Fialova, Petra Cetkovska, Spyridon Gkalpakiotis, Alena Machovcova, Petr Arenberger, Jiri Stork, Tomas Dolezal, Martin Tichy, the BIOREP study group, Zdenek Antal, Monika Balaz, Jirina Bartonova, Gabriela Behrami, Linda Blahova, Petr Bohac, Martin Cetkovsky, Dominika Diamantova, Magdalena Dobiasova, Olga Filipovska, Jana Foldesova, Martina Grycova, Eduard Hrnciř, Jiri Horazdovsky, Katerina Hrazdirova, Monika Hudymacova, Marie Jandova, Hana Janatova, Lucie Jaresova, Ludmila Kajtmanova, Frantisek Keznikl, Peter Kicko, Zuzana Kondasova, Sarka Kozojedova, Jiri Korda, Jana Kreisslova, Anezka Kreisslova, Silvie Krchova, Lenka Kulmanova, Natalie Kunesova, Zdenka Kysilka, Iva Lomicova, Romana Machackova, Barbora Machackova, Lukas Mericko, Miroslav Necas, Helena Nemcova, Radka Neumannova, Michaela Novakova, Jitka Osmerova, Veronika Pallova, Veronika Patavova, Lucie Petrů, Marie Policarova, Tomas Pospisil, Simona Risianova, Filip Rob, Marcela Rozkosova, Libuse Sazmova, Jaroslav Sevcik, Iva Schmidtmayerova, Martin Sicha, Kristyna Sokolova, Eliska Stankova, Jan Sternbersky, Ivana Strouhalova, David Stuchlik, Alena Stumpfova, Katerina Svarcova, Katerina Tepla, Hana Tomkova, Jana Tresnak Hercogova, Simona Vachatova, Yvetta Vantuchova, Ivana Vejrova, Iva Zampachova +76 morewiley +1 more source